The COH agonist protocol was use of other than a midluteal long GnRH-agonist (Daphiline Beaufour IPSEN, France, 0.8–1.0mg, subcutaneously) suppressive protocol or short GnRH-agonist (Daphiline Beaufour IPSEN, France, 0.05–0.1mg, subcutaneously) suppressive protocol (agonist group).
Source: wiktionary